滚动资讯
FierceBiotechADA: AZ’s oral GLP-1 shows ‘competitive efficacy’ in phase 2, setting stage for pivotal programFierceBiotechLilly moves deeper into Alzheimer’s research with AlzeCure licensing dealFierceBiotechCancer biotech Parabilis ups IPO plans to potentially record-setting $637MEndpoints NewsEndpoints Women in Biopharma: Nominate for 2026Lonza NewsAmMax Bio licenses ADC technology from Lonza - The Pharma LetterFDA News ReleasesFDA Expands Sunscreen Options for the First Time in 20 YearsEndpoints NewsPharma and biotech salaries: Top-paying companies of 2025FierceBiotech罗氏坚持在德国投资6亿欧元用于诊断业务，但警告未来存在风险10x Genomics Blog10x Genomics (TXG) 通过收购 Proteintech Genomics 扩展能力 - GuruFocusFierceBiotechCeQur融资1亿美元的E轮融资 推动胰岛素贴片商业化10x Genomics News10x Genomics收购Proteintech基因组学部门 - Investing.comPharmaVoice拥有前景广阔的MASH资产、保肌型GLP-1及新任CEO，Rivus蓄势待发。

资讯库

最新 最旧 清除
@Recursion
总数 42
来源 Recursion
搜索 --